Mark Sculpher : Citation Profile

18

H index

28

i10 index

1286

Citations

RESEARCH PRODUCTION:

67

Articles

23

Papers

2

Books

4

Chapters

EDITOR:

1

Books edited

RESEARCH ACTIVITY:

   30 years (1995 - 2025). See details.
   Cites by year: 42
   Journals where Mark Sculpher has often published
   Relations with other researchers
   Recent citing documents: 83.    Total self citations: 40 (3.02 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psc810
   Updated: 2026-03-28    RAS profile: 2025-05-29    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Walker, Simon (4)

Revill, Paul (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mark Sculpher.

Is cited by:

Brouwer, Werner (45)

Claxton, Karl (35)

Walker, Simon (26)

van Exel, Job (16)

Asaria, Miqdad (15)

EPSTEIN, DAVID (11)

Culyer, Anthony (11)

Soares, Marta (10)

Aas, Eline (9)

Russell, Louise (7)

Brazier, John (7)

Cites to:

Claxton, Karl (92)

Brouwer, Werner (22)

Culyer, Anthony (22)

Rice, Nigel (20)

Walker, Simon (19)

Johannesson, Magnus (17)

Asaria, Miqdad (15)

McCabe, Christopher (13)

Devlin, Nancy (13)

Mullahy, John (11)

Brazier, John (10)

Main data

Where Mark Sculpher has published?

Journals with more than one article published# docs
Health Economics20
Medical Decision Making20
PharmacoEconomics13
PLOS ONE5
Applied Health Economics and Health Policy3
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York16
Centre for Health Economics and Policy Analysis Working Paper Series / Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada3

Recent works citing Mark Sculpher (2025 and 2024)

YearTitle of citing document
2025A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients. (2025). Manca, Fabio ; Solimando, Antonio Giovanni ; Bilancia, Massimo ; Ria, Roberto ; Vacca, Angelo. In: Computational Statistics & Data Analysis. RePEc:eee:csdana:v:206:y:2025:i:c:s0167947325000064.

Full description at Econpapers || Download paper

2024An evaluation of the impact of mitigation policies on health and the economy by managing social distancing during outbreaks. (2024). Caferra, Rocco ; Morone, Piergiuseppe ; Lopolito, Antonio ; Nigri, Andrea. In: Evaluation and Program Planning. RePEc:eee:epplan:v:103:y:2024:i:c:s0149718924000077.

Full description at Econpapers || Download paper

2024Economic Evaluations of Obesity-Targeted Sugar-Sweetened Beverage (SSB) Taxes–A Review to Identify Methodological Issues. (2024). Khoo, Terence ; Goodall, Stephen ; de Abreu, Richard ; Cronin, Paula ; Thiboonboon, Kittiphong. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000861.

Full description at Econpapers || Download paper

2025Projected costs of long-term care for older people in England: The impacts of housing quality improvements. (2025). Hu, BO ; Silva-Ribeiro, Wagner ; Cartagena-Farias, Javiera ; Brimblecombe, Nicola. In: Health Policy. RePEc:eee:hepoli:v:152:y:2025:i:c:s0168851025000028.

Full description at Econpapers || Download paper

2024Competition, value-based prices and incentives to research personalised drugs. (2024). LEVAGGI, ROSELLA. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

Full description at Econpapers || Download paper

2025Modeling cost-effectiveness analysis of treatment sequencing. (2025). Keller, Robin L ; Bai, Jiaru ; del Campo, Cristina. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:99:y:2025:i:c:s003801212500059x.

Full description at Econpapers || Download paper

2024A happiness approach to valuing health states for children. (2024). Devlin, Nancy ; Huang, LI ; Dalziel, Kim ; Chen, Gang. In: Social Science & Medicine. RePEc:eee:socmed:v:348:y:2024:i:c:s0277953624002466.

Full description at Econpapers || Download paper

2025Horizontal equity in primary care financing: An assessment of payments to general practices in England, 2014–2022. (2025). Sutton, Matt ; Anselmi, Laura ; Lo, Charlene. In: Social Science & Medicine. RePEc:eee:socmed:v:373:y:2025:i:c:s0277953625003260.

Full description at Econpapers || Download paper

2024Economic costs of perinatal depression and anxiety in a lower-middle income country: Pakistan. (2024). Sikander, Siham ; Husain, Nusrat ; Chaudhry, Nasim ; Alvi, Mohsin ; Knapp, Martin ; Tayyaba, Kiran ; Bauer, Annette ; Gregoire, Alain ; Wagas, Ahmed ; Malik, Abid. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:122650.

Full description at Econpapers || Download paper

2025Economic implications of off-road cycle lanes to increase physical activity and reduce sex and gender differences in the risk of dementia. (2025). Cyhlarova, Eva ; Aguzzoli, Elisa ; Knapp, Martin ; Chadha, Antonella Santuccione ; Castroaldrete, Laura ; Walbaum, Magdalena. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:127515.

Full description at Econpapers || Download paper

2025A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop. (2025). Almudaiyan, Lolwa Hamad ; Abu, Laila Carolina ; Kanavos, Panos ; Al-Najjar, Amal Hassan ; Tarricone, Rosanna ; Almuhsin, Asma Abdulaziz ; Espin, Jaime ; Al-Omar, Hussain Abdulrahman ; Maraiki, Fatma ; Alamre, Jehan ; Alyahya, Khalid ; Khan, Mansoor Ahmed ; Yousef, Consuela Cheriece ; Altawil, Esraa S ; Almodaimegh, Hind. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:128168.

Full description at Econpapers || Download paper

2024Cost-effectiveness of drug consumption rooms in France: a modelling study. (2024). Auriacombe, Marc ; Lalanne, Laurence ; Jauffret-Roustide, Marie ; Maradan, Gwenalle ; Madrid, Lalia Briand ; Donadille, Ccile ; Cousien, Anthony ; Boyer, Sylvie ; Roux, Perrine. In: Post-Print. RePEc:hal:journl:hal-04720831.

Full description at Econpapers || Download paper

2025DYNAMIC BARGAINING OVER PUBLIC INSURANCE COVERAGE FOR DRUGS IN AUSTRALIA. (2025). Harris, Anthony ; Li, Jingjing. In: Centre for Health Economics, Monash University. RePEc:mhe:chemon:2025-09.

Full description at Econpapers || Download paper

2025Cost-effectiveness of community-based integrated care model for patients with diabetes and depressive symptoms. (2025). Shi, Zhenyu ; Guan, Xiaolong ; Zhu, Dawei ; He, Ping ; Wang, Yanshang ; Guo, Dan ; Xia, Yiqi. In: Nature Communications. RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58120-x.

Full description at Econpapers || Download paper

2025Cost-effectiveness analysis of screening for congenital Chagas disease in a non-endemic area. (2025). Damiani, Gianfranco ; Gianino, Maria Michela ; Barbera, Giulia ; Olivo, Lia ; Angheben, Andrea ; Marraffa, Pietro ; Dentato, Matteo ; Nurchis, Mario Cesare. In: Nature Communications. RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63760-0.

Full description at Econpapers || Download paper

2024Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial. (2024). Perelman, Julian ; Lunet, Nuno ; Rodrigues, Antnio Teixeira ; Simes, Joao Braga ; Guerreiro, Jos Pedro ; Monteiro, Luis ; Romano, Snia. In: PLOS ONE. RePEc:plo:pone00:0298181.

Full description at Econpapers || Download paper

2024Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China. (2024). Mi, Xiufang ; He, Chaoneng ; Ding, Haiying ; Fang, Luo ; Shu, QI ; Zhu, Junfeng ; Zhong, Like ; Xin, Wenxiu ; Xu, Xinglu. In: PLOS ONE. RePEc:plo:pone00:0302961.

Full description at Econpapers || Download paper

2024Cost-effectiveness of prophylactic ramosetron in the prevention of postoperative nausea and vomiting. (2024). Suh, David ; Kim, Chul-Min ; Jung, Sun-Young ; Lee, Seung-Mi. In: PLOS ONE. RePEc:plo:pone00:0309592.

Full description at Econpapers || Download paper

2024Economic evaluation of an adjunctive intraocular and peri-ocular steroid vitreoretinal surgery for open globe trauma: Cost-effectiveness of the ASCOT randomised controlled trial. (2024). Anthony, Bethany F ; Charteris, David G ; Ezeofor, Victory Segun ; Banerjee, Philip J ; Murphy, Caroline ; Kelly, Joanna ; Robertson, Elizabeth ; Bunce, Catey ; Cornelius, Victoria R ; Cro, Suzie ; Casswell, Edward J ; Bryning, Lucy ; Edwards, Rhiannon Tudor. In: PLOS ONE. RePEc:plo:pone00:0311158.

Full description at Econpapers || Download paper

2025Cost-effectiveness of the SMILE intervention compared with usual care for people with severe mental illness: A randomized clinical trial. (2025). van Meijel, Berno ; el Alili, Mohamed ; Adriaanse, Marcel ; van Tulder, Maurits W. In: PLOS ONE. RePEc:plo:pone00:0313100.

Full description at Econpapers || Download paper

2025Economic impact of the Elecsys anti-Müllerian hormone Plus immunoassay for anti-Müllerian hormone testing as part of polycystic ovary syndrome assessment in the United Kingdom. (2025). Franks, Stephen ; Piltonen, Terhi ; Mawson, Rebecca ; Laven, Joop ; Olziersky, Anna-Maria ; Garay, Osvaldo Ulises ; Sillman, Johanna. In: PLOS ONE. RePEc:plo:pone00:0326162.

Full description at Econpapers || Download paper

2025Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis. (2025). Tan, Chongqing ; Zhang, Lei ; Peng, YE ; Wang, Liting ; She, Zhihua ; Xiang, Heng. In: PLOS ONE. RePEc:plo:pone00:0337606.

Full description at Econpapers || Download paper

2024Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models. (2024). Ibarrondo, Oliver ; Mar, Javier ; Larraaga, Igor ; Alarid-Escudero, Fernando ; Arrospide, Arantzazu ; Blasco-Aguado, Rubn. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:4:p:359-364.

Full description at Econpapers || Download paper

2024Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway. (2024). Henkel, Pia S ; Sletner, Line ; Pedersen, Kine ; Burger, Emily A. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:4:p:380-392.

Full description at Econpapers || Download paper

2024Calculating the Expected Net Benefit of Sampling for Survival Data: A Tutorial and Case Study. (2024). Vervaart, Mathyn. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:7:p:719-741.

Full description at Econpapers || Download paper

2024Accurate EVSI Estimation for Nonlinear Models Using the Gaussian Approximation Method. (2024). Heath, Anna ; Jalal, Hawre ; Li, Linke. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:7:p:787-801.

Full description at Econpapers || Download paper

2024Methods to Quantify the Importance of Parameters for Model Updating and Distributional Adaptation. (2024). Gutacker, Nils ; Walker, Simon ; Griffin, Susan ; Glynn, David. In: Medical Decision Making. RePEc:sae:medema:v:44:y:2024:i:7:p:802-810.

Full description at Econpapers || Download paper

2024VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives. (2024). Ribari, Elizabeta ; Veli, Ismar ; Bobinac, Ana. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:1:d:10.1007_s40258-023-00829-1.

Full description at Econpapers || Download paper

2024Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom. (2024). Kindred, Max ; Shabrina, Zahratu ; Zakiyah, Neily. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:1:d:10.1007_s40258-023-00839-z.

Full description at Econpapers || Download paper

2024Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?. (2024). Dakin, Helen ; Tsiachristas, Apostolos. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:3:d:10.1007_s40258-023-00858-w.

Full description at Econpapers || Download paper

2024Simplified Methods for Modelling Dependent Parameters in Health Economic Evaluations: A Tutorial. (2024). Volodin, Andrei ; Rios, Juan David ; Wang, Myra ; Liu, Sichen ; Schaink, Alexis K ; Xie, Xuanqian. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:3:d:10.1007_s40258-024-00874-4.

Full description at Econpapers || Download paper

2024Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study. (2024). Whittaker, William ; Hinde, Sebastian ; Hunter, Rachael Maree ; Franklin, Matthew ; Richardson, Gerry. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:4:d:10.1007_s40258-024-00875-3.

Full description at Econpapers || Download paper

2024Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment. (2024). Lauerer, Michael ; Engel, Lidia ; Nagel, Eckhard ; Henzler, Dennis ; Mihalopoulos, Cathrine ; Brown, Vicki ; Darab, Mohsen Ghaffari. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:4:d:10.1007_s40258-024-00878-0.

Full description at Econpapers || Download paper

2024A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. (2024). Wright, Stuart J ; Payne, Katherine ; Rogers, Gabriel ; Gray, Ewan ; Donten, Anna. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:4:d:10.1007_s40258-024-00887-z.

Full description at Econpapers || Download paper

2025Onasemnogene Abeparvovec Gene Therapy and Risdiplam for the Treatment of Spinal Muscular Atrophy in Thailand: A Cost-Utility Analysis. (2025). Srinonprasert, Varalak ; Ponragdee, Kunnatee ; Prawjaeng, Juthamas ; Khuntha, Sarayuth ; Leelahavarong, Pattara ; Sanmaneechai, Oranee. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:2:d:10.1007_s40258-024-00915-y.

Full description at Econpapers || Download paper

2025Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations. (2025). Remme, Michelle ; Ramprakash, Rajalakshmi ; Vijayasingham, Lavanya ; McHenga, Martina. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:2:d:10.1007_s40258-024-00930-z.

Full description at Econpapers || Download paper

2025Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies. (2025). Abdali, Zainab ; Avar, Tuba Saygin ; Jowett, Sue ; Jackson, Louise ; Elmusharaf, Khalifa ; Syed, Muslim. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:4:d:10.1007_s40258-024-00940-x.

Full description at Econpapers || Download paper

2025Evaluating Access Improving Interventions: An Economic Evaluation of Surgical Task-Shifting for C-Sections in Sierra Leone. (2025). Jayne, David ; Ensor, Tim ; Shinkins, Bethany ; Dawkins, Bryony ; Meads, David ; Bolkan, Hkon A ; Duinen, Alex J ; Ashley, Thomas. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:4:d:10.1007_s40258-025-00965-w.

Full description at Econpapers || Download paper

2024Development and Content Validation of the 10-item Well-being Instrument (WiX) for use in Economic Evaluation Studies. (2024). Brouwer, Werner ; Voormolen, Daphne C ; Bekker-Grob, Esther W ; Exel, Job. In: Applied Research in Quality of Life. RePEc:spr:ariqol:v:19:y:2024:i:2:d:10.1007_s11482-023-10241-5.

Full description at Econpapers || Download paper

2024Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma. (2024). Auprin, Anne ; Lueza, Branger ; Gross, Thomas G ; Pillon, Marta ; Bonastre, Julia ; Zsros, Jzsef ; Patte, Catherine ; Amos, G A ; Simonin, Mathieu ; Uyttebroeck, Anne ; Cska, Monika ; Delgado, Rafael F ; Minard-Colin, Vronique ; Rigaud, Charlotte. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:2:d:10.1007_s10198-023-01581-y.

Full description at Econpapers || Download paper

2024Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan. (2024). Kashiwa, Munenobu. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01602-w.

Full description at Econpapers || Download paper

2024Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease. (2024). Stargardt, Tom ; Bokemeyer, Bernd ; Steiner, Isa Maria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01603-9.

Full description at Econpapers || Download paper

2024Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling. (2024). Boespflug, Nicolas ; Wittwer, Jrme ; Bnard, Antoine. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01613-7.

Full description at Econpapers || Download paper

2024Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma. (2024). Schlueter, Max ; Laramee, Philippe ; Meyer, Nicolas ; Macabeo, Brengre ; Nikolaidis, Georgios F ; Trouiller, Jean-Baptiste ; Gerlier, Laetitia. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01614-6.

Full description at Econpapers || Download paper

2024Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland. (2024). Hulst, Marinus ; Livings, Christopher J ; Dunton, Kyle J ; Seddik, Ahmed H ; Freriks, Roel D ; Jong, Lisa A ; Postma, Maarten J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01617-3.

Full description at Econpapers || Download paper

2024Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication. (2024). Ramos-Goi, Juan Manuel ; Chang, Jen-Yu Amy ; Lin, Hsiang-Wen ; Hsu, Chien-Ning ; Luo, Nan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:6:d:10.1007_s10198-023-01642-2.

Full description at Econpapers || Download paper

2024Projected costs of informal care for older people in England. (2024). Jadoolal, Shari ; Wittenberg, Raphael ; Brimblecombe, Nicola ; Cartagena-Farias, Javiera ; Hu, BO. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:6:d:10.1007_s10198-023-01643-1.

Full description at Econpapers || Download paper

2024Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis. (2024). Andreoni, Massimo ; Kondili, Loreta A ; Mennini, Francesco Saverio ; Marcellusi, Andrea. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:7:d:10.1007_s10198-023-01652-0.

Full description at Econpapers || Download paper

2024Impact of Long COVID on productivity and informal caregiving. (2024). Kwon, Joseph ; Mullard, Jordan ; Mir, Ghazala ; Rayner, Clare ; Delaney, Brendan ; Petrou, Stavros ; Milne, Ruairidh ; Lawrence, Roman Rocha ; Sivan, Manoj. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:7:d:10.1007_s10198-023-01653-z.

Full description at Econpapers || Download paper

2025The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries. (2025). Mokri, Hamraz ; Baal, Pieter ; Mlken, Maureen Rutten-Van. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:1:d:10.1007_s10198-024-01690-2.

Full description at Econpapers || Download paper

2025Monetary value of health—a practical decision-making framework combining equity considerations and WTP. (2025). Ribari, Elizabeta ; Veli, Ismar ; Bobinac, Ana. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:2:d:10.1007_s10198-024-01693-z.

Full description at Econpapers || Download paper

2025Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens. (2025). Quist, Sara W ; Te, Sophie ; Freriks, Roel D ; Postma, Maarten J ; Hoyng, Carel B ; Asten, Freekje. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:3:d:10.1007_s10198-024-01715-w.

Full description at Econpapers || Download paper

2025Drug pricing models, no ‘one-size-fits-all’ approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape. (2025). Manders, Evert A ; den Berg, Sibren ; Visser, Saco J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:4:d:10.1007_s10198-024-01731-w.

Full description at Econpapers || Download paper

2025Preferences for health-related quality of life: do they vary by age? A systematic literature review on the EQ-5D measure. (2025). Mitchell, Paul Mark ; Cochrane, Madeleine ; Alabbad, Alhanouf. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:7:d:10.1007_s10198-025-01766-7.

Full description at Econpapers || Download paper

2024Do analysts predict managed or unmanaged earnings?. (2024). Mard, Yves ; Mustafa, Qazi Ghulam ; Aubert, Francois. In: Eurasian Business Review. RePEc:spr:eurasi:v:14:y:2024:i:2:d:10.1007_s40821-023-00250-7.

Full description at Econpapers || Download paper

2024Research trends in contemporary health economics: a scientometric analysis on collective content of specialty journals. (2024). Bekker-Grob, Esther W ; Haghani, Milad ; Zwack, Clara C. In: Health Economics Review. RePEc:spr:hecrev:v:14:y:2024:i:1:d:10.1186_s13561-023-00471-6.

Full description at Econpapers || Download paper

2024Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis. (2024). Daroudi, Rajabali ; Roudini, Kamran ; Alvar, Amirhossein Zarei ; Ghadimi, Nashmil ; Kaveh, Sara. In: Health Economics Review. RePEc:spr:hecrev:v:14:y:2024:i:1:d:10.1186_s13561-024-00571-x.

Full description at Econpapers || Download paper

2025Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand. (2025). Li, Ning ; Gai, Ruoyan ; Suo, Yue ; Lian, Dai ; Chen, Yingyao ; Liu, Shimeng ; Zhang, Mingdong ; Zhao, Jiaxin ; Xiao, Dunming ; Ren, Yunfeng. In: Health Economics Review. RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00669-w.

Full description at Econpapers || Download paper

2024Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada. (2024). Sarma, Sisira ; Kim, Richard B ; Cipriano, Lauren E ; Zaric, Gregory S ; Hafeez, Aneeka ; Schwarz, Ute I. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-023-01309-z.

Full description at Econpapers || Download paper

2024A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus. (2024). Mateus, Ceu ; Hollingsworth, Bruce ; Antoniou, Marina ; Titman, Andrew. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-023-01312-4.

Full description at Econpapers || Download paper

2024The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations. (2024). Hill-McManus, Daniel. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-023-01313-3.

Full description at Econpapers || Download paper

2024A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework. (2024). Aas, Eline ; Kuntz, Karen M ; Burger, Emily A ; Kunst, Natalia. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:4:d:10.1007_s40273-023-01341-z.

Full description at Econpapers || Download paper

2024Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA. (2024). Lin, Shih-Wen ; Matasar, Matthew ; Wu, Mei ; Kim, Eunice ; Shapouri, Sheila ; Paris, Hlne ; Bercaw, Eric. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:5:d:10.1007_s40273-024-01358-y.

Full description at Econpapers || Download paper

2024Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators. (2024). Heath, Anna ; Baio, Gianluca ; Welton, Nicky J ; Manolopoulou, Ioanna. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:5:d:10.1007_s40273-024-01372-0.

Full description at Econpapers || Download paper

2024Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. (2024). Chawla, Anjulika ; Dong, Olivia M ; Mladsi, Deirdre ; Morse, KC ; Andemariam, Biree ; Paramore, Clark ; Zhang, Lixin ; Shah, Nirmish ; Herring, William L ; Gallagher, Meghan E ; Leiding, Jennifer W. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:6:d:10.1007_s40273-024-01385-9.

Full description at Econpapers || Download paper

2024Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results. (2024). Marks, Yanara ; Pechlivanoglou, Petros ; Hoch, Jeffrey S ; Heath, Anna. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:7:d:10.1007_s40273-024-01374-y.

Full description at Econpapers || Download paper

2024Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature. (2024). Wilberforce, Mark ; Davies, Linda M ; Shields, Gemma E ; Bullement, Ash ; Verma, Arpana ; Stevens, Warren ; Farragher, Tracey ; Clarkson, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:7:d:10.1007_s40273-024-01377-9.

Full description at Econpapers || Download paper

2024Rapid Assessment of the Need for Evidence: Applying the Principles of Value of Information to Research Prioritisation. (2024). Gc, Vijay ; Claxton, Karl ; Glynn, David ; Rothery, Claire ; Littlewood, Chris. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:9:d:10.1007_s40273-024-01403-w.

Full description at Econpapers || Download paper

2025Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications. (2025). Palmer, Andrew J ; Mei, Ingrid ; Taylor, Bruce V ; Ahmad, Hasnat ; Ngwa, Valery Fuh ; Henson, Glen J ; Campbell, Julie A. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:2:d:10.1007_s40273-024-01417-4.

Full description at Econpapers || Download paper

2025A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology. (2025). Saing, Sopany ; Koffijberg, Hendrik ; Vriens, Dennis ; Geus-Oei, Lioe-Fee ; Feria, Rafael Emilio ; Mossel, Sietse. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:2:d:10.1007_s40273-024-01447-y.

Full description at Econpapers || Download paper

2025Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia. (2025). Parkinson, Bonny ; Sinha, Kompal ; Gu, Yuanyuan ; Jeet, Varinder ; Hoyle, Martin ; Chen, Qunfei. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:3:d:10.1007_s40273-024-01446-z.

Full description at Econpapers || Download paper

2025A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment. (2025). Clements, Mark S ; Dickman, Paul W ; Chen, Enoch Yi-Tung. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:3:d:10.1007_s40273-024-01457-w.

Full description at Econpapers || Download paper

2025A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care. (2025). Neslusan, Cheryl A ; Willis, Michael S ; Nilsson, Andreas. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:6:d:10.1007_s40273-025-01478-z.

Full description at Econpapers || Download paper

2025Societal Versus Healthcare Perspectives on the Cost Effectiveness of Ocrelizumab for Treatment of Primary Progressive Multiple Sclerosis in Aotearoa New Zealand. (2025). Mottershead, John ; Schousboe, Carsten ; Campbell, Julie A ; Milne, Richard J. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:8:d:10.1007_s40273-025-01486-z.

Full description at Econpapers || Download paper

2024Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark. (2024). Groot, Carin Uyl-De ; Redekop, William Ken ; Johanna, Milanne Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:8:y:2024:i:2:d:10.1007_s41669-023-00461-8.

Full description at Econpapers || Download paper

2024A Canadian Simulation Model for Major Depressive Disorder: Study Protocol. (2024). Cressman, Sonya ; Landry, Ginny ; McGrail, Kim ; Ghanbarian, Shahzad ; Austin, Jehannine ; Bunka, Mary ; Bryan, Stirling ; Conte, Tania ; Peterson, Sandra ; Vijh, Rohit ; Price, Morgan ; Schuetz, Christian ; Erickson, David ; Edwards, Louisa ; Riches, Linda. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:8:y:2024:i:3:d:10.1007_s41669-024-00481-y.

Full description at Econpapers || Download paper

2025Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohns Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study. (2025). Freiman, Erica Stivelman ; Mac, Stephen ; Fischer, Aren ; Rand, Kim ; Ramos-Goi, Juan M ; Marshall, John K. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:9:y:2025:i:1:d:10.1007_s41669-024-00523-5.

Full description at Econpapers || Download paper

2025Semaglutide 2.4 mg versus Liraglutide 3 mg for the Treatment of Obesity in Greece: A Short-Term Cost-Effectiveness Analysis. (2025). Maniadakis, Nikolaos ; Papantoniou, Panagiotis. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:9:y:2025:i:3:d:10.1007_s41669-025-00561-7.

Full description at Econpapers || Download paper

2025Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults. (2025). Morin, Charles M ; Greenwood, Berkeley ; Walker, Andrew ; Miller, Paul ; Palmer, Stephen ; Graham, Peter ; Cooper, Jacie ; Chalet, Franois-Xavier ; Briggs, Andrew H. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:9:y:2025:i:3:d:10.1007_s41669-025-00567-1.

Full description at Econpapers || Download paper

2025Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan. (2025). Goswami, Hardik ; Tajima, Atsushi ; Puenpatom, Amy ; Matsuki, Taizo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:9:y:2025:i:4:d:10.1007_s41669-025-00578-y.

Full description at Econpapers || Download paper

2025The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador. (2025). Yajamn-Villamarn, Ricardo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:9:y:2025:i:5:d:10.1007_s41669-025-00585-z.

Full description at Econpapers || Download paper

2024Integrating decision modeling and machine learning to inform treatment stratification. (2024). Soares, Marta ; Hatamyar, Julia ; Giardina, John ; Glynn, David ; Pandya, Ankur ; Kreif, Noemi. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:8:p:1772-1792.

Full description at Econpapers || Download paper

2025Value‐Based Pricing for Drugs With Uncertain Clinical Benefits. (2025). Jiao, Boshen ; Verguet, Stphane ; Li, Meng ; Hsieh, Yuli Lily. In: Health Economics. RePEc:wly:hlthec:v:34:y:2025:i:4:p:780-790.

Full description at Econpapers || Download paper

Mark Sculpher has edited the books:

YearTitleTypeCited

Works by Mark Sculpher:

YearTitleTypeCited
2015Country-level cost-effectiveness thresholds: initial estimates and the need for further research In: Working Papers.
[Full Text][Citation analysis]		paper48
2016Supporting the development of an essential health package: principles and initial assessment for Malawi In: Working Papers.
[Full Text][Citation analysis]		paper3
2017Scoping review on social care economic evaluation methods In: Working Papers.
[Full Text][Citation analysis]		paper0
2019Economic analysis for health benefits package design In: Working Papers.
[Full Text][Citation analysis]		paper0
1999A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis In: Working Papers.
[Full Text][Citation analysis]		paper0
2000Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling In: Working Papers.
[Full Text][Citation analysis]		paper7
2021Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characteri In: Working Papers.
[Full Text][Citation analysis]		paper0
2007Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions In: Working Papers.
[Full Text][Citation analysis]		paper12
2009MRC-NICE scoping project: identifying the national institute for health and clinical excellence’s methodological research priorities and an initial set of priorities In: Working Papers.
[Full Text][Citation analysis]		paper2
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]		paper44
2005The value of implementation and the value of information: combined and uneven development In: Working Papers.
[Full Text][Citation analysis]		paper19
2008The Value of Implementation and the Value of Information: Combined and Uneven Development.(2008) In: Medical Decision Making.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 19		article
2011Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS In: Working Papers.
[Full Text][Citation analysis]		paper11
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]		paper25
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper43
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]		paper8
2006Defining and characterising structural uncertainty in decision analytic models In: Working Papers.
[Full Text][Citation analysis]		paper7
2024We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment In: Health Economics, Policy and Law.
[Full Text][Citation analysis]		article0
2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations In: Health Policy.
[Full Text][Citation analysis]		article32
2002Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions In: Social Science & Medicine.
[Full Text][Citation analysis]		article4
2019Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]		paper20
2016Using electronic health records to predict costs and outcomes in stable coronary artery disease In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]		paper6
2012Decision-making with Uncertainty: The Value of Information In: Chapters.
[Full Text][Citation analysis]		chapter0
2006Decision-making with Uncertainty: The Value of Information.(2006) In: Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		chapter
1999Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
1999Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
1999Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]		paper0
2000Productivity Costs: Principles and Practice in Economic Evaluation In: Monograph.
[Full Text][Citation analysis]		book13
2006Decision Modelling for Health Economic Evaluation In: OUP Catalogue.
[Citation analysis]		book424
2022Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates In: PLOS Neglected Tropical Diseases.
[Full Text][Citation analysis]		article0
2014Cost-Effectiveness Analysis of Acupuncture, Counselling and Usual Care in Treating Patients with Depression: The Results of the ACUDep Trial In: PLOS ONE.
[Full Text][Citation analysis]		article0
2017Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee In: PLOS ONE.
[Full Text][Citation analysis]		article0
2018Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care In: PLOS ONE.
[Full Text][Citation analysis]		article1
2019Adherence to the iDSI reference case among published cost-per-DALY averted studies In: PLOS ONE.
[Full Text][Citation analysis]		article2
2025Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in Nepal In: PLOS ONE.
[Full Text][Citation analysis]		article0
2000Income Effects of Reduced Health and Health Effects of Reduced Income: In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2004Unfinished Symphony: A Tribute to the Life and Career of Bernie O€™Brien (1959€“2004) In: Medical Decision Making.
[Full Text][Citation analysis]		article0
2005Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model In: Medical Decision Making.
[Full Text][Citation analysis]		article6
2005Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response In: Medical Decision Making.
[Full Text][Citation analysis]		article10
2006An Iterative Bayesian Approach to Health Technology Assessment: Application to a Policy of Preoperative Optimization for Patients Undergoing Major Elective Surgery In: Medical Decision Making.
[Full Text][Citation analysis]		article7
2007Efficiency, Equity, and Budgetary Policies In: Medical Decision Making.
[Full Text][Citation analysis]		article18
2007Cost-Effectiveness Analysis Using Data from Multinational Trials: The Use of Bivariate Hierarchical Modeling In: Medical Decision Making.
[Full Text][Citation analysis]		article6
2008Identifying Research Priorities: The Value of Information Associated with Repeat Screening for Age-Related Macular Degeneration In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2011Catalogue of EQ-5D Scores for the United Kingdom In: Medical Decision Making.
[Full Text][Citation analysis]		article8
2012Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-Related Quality of Life in Patients with Advanced HIV In: Medical Decision Making.
[Full Text][Citation analysis]		article0
2012Model Parameter Estimation and Uncertainty Analysis In: Medical Decision Making.
[Full Text][Citation analysis]		article33
2013Methods Development for Health Technology Assessment In: Medical Decision Making.
[Full Text][Citation analysis]		article0
2014The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2017How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants In: Medical Decision Making.
[Full Text][Citation analysis]		article4
2018Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2018Future Directions for Cost-effectiveness Analyses in Health and Medicine In: Medical Decision Making.
[Full Text][Citation analysis]		article2
2020Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts In: Medical Decision Making.
[Full Text][Citation analysis]		article3
2021Authors€™ Response to: €œHealth Opportunity Costs and Expert Elicitation: A Comment on Soares et al.€ by Sampson, Firth, and Towse In: Medical Decision Making.
[Full Text][Citation analysis]		article3
2022Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making In: Medical Decision Making.
[Full Text][Citation analysis]		article0
2014What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2019Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article23
2025Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2010An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2005Estimating utility data from clinical indicators for patients with stable angina In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article7
2000Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2006Assessing Generalisability in Model-Based Economic Evaluation Studies In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2007A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2007Recombinant Erythropoietin for Chemotherapy-Related Anaemia In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2012Real Economics Needs to Reflect Real Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]		article27
2013Acknowledging Patient Heterogeneity in Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]		article4
2016Should the Lambda (λ) Remain Silent? In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator? In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2021Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2022Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2023Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How? In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2025A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2001Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis In: Health Economics.
[Full Text][Citation analysis]		article18
2001Representing uncertainty: the role of cost‐effectiveness acceptability curves In: Health Economics.
[Full Text][Citation analysis]		article78
2002Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors reply In: Health Economics.
[Full Text][Citation analysis]		article0
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]		article71
2005Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models In: Health Economics.
[Full Text][Citation analysis]		article20
2005Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility In: Health Economics.
[Full Text][Citation analysis]		article30
2006Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion In: Health Economics.
[Full Text][Citation analysis]		article20
2006Evidence synthesis, parameter correlation and probabilistic sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]		article12
2006Whither trial‐based economic evaluation for health care decision making? In: Health Economics.
[Full Text][Citation analysis]		article42
2010Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods In: Health Economics.
[Full Text][Citation analysis]		article3
2011Dangerous omissions: the consequences of ignoring decision uncertainty In: Health Economics.
[Full Text][Citation analysis]		article13
2015CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? In: Health Economics.
[Full Text][Citation analysis]		article24
2017Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs In: Health Economics.
[Full Text][Citation analysis]		article15
2018Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system In: Health Economics.
[Full Text][Citation analysis]		article0
2018How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework In: Health Economics.
[Full Text][Citation analysis]		article2
2020Distributional cost effectiveness analysis of West Yorkshire low emission zone policies In: Health Economics.
[Full Text][Citation analysis]		article0
2021Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems In: Health Economics.
[Full Text][Citation analysis]		article0
2024Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required In: Health Economics.
[Full Text][Citation analysis]		article1
1995Sensitivity analysis in economic evaluation: A review of published studies In: Health Economics.
[Full Text][Citation analysis]		article14
1998The cost‐effectiveness of preference‐based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia In: Health Economics.
[Full Text][Citation analysis]		article1
2020Cost-Effectiveness Thresholds: Guiding Health Care Spending for Population Health Improvement In: World Scientific Book Chapters.
[Full Text][Citation analysis]		chapter3
2020Supporting the Development of Health Benefits Packages (HBPs): Principles and Initial Assessment for Malawi In: World Scientific Book Chapters.
[Full Text][Citation analysis]		chapter0
1995Economic Evaluation in Health Care Research and Development: Undertake it Early and Often In: Discussion Papers.
[Full Text][Citation analysis]		paper2
1996Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation In: Discussion Papers.
[Full Text][Citation analysis]		paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated March, 14 2025. Contact: CitEc Team